LAMTOR5 and hepatocellular carcinoma: As shown in Figure 2(b), the expression levels of HBXIP were notably increased in the liver tissues of patients with HCC (HBV + HCC and HBV-HCC groups) as compared to corresponding adjacent noncancerous liver tissues (HBV + NT and HBV-NT groups) (p < 0.05) and higher in the HBV + HCC and HBV + NT groups than that in the HBV-HCC and HBV-NT groups (p < 0.05).